ShockWave Medical Statistics
Total Valuation
Yimutian has a market cap or net worth of $520.42 million. The enterprise value is $558.48 million.
| Market Cap | 520.42M |
| Enterprise Value | 558.48M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Yimutian has 114.38 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 114.38M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.19 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 24.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -57.26% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $34,150 |
| Profits Per Employee | -$7,461 |
| Employee Count | 657 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yimutian had revenue of $22.44 million and -$4.90 million in losses. Loss per share was -$0.04.
| Revenue | 22.44M |
| Gross Profit | 18.13M |
| Operating Income | -4.72M |
| Pretax Income | -4.84M |
| Net Income | -4.90M |
| EBITDA | n/a |
| EBIT | n/a |
| Loss Per Share | -$0.04 |
Balance Sheet
The company has $860,811 in cash and $38.93 million in debt, giving a net cash position of -$38.06 million or -$0.33 per share.
| Cash & Cash Equivalents | 860,811 |
| Total Debt | 38.93M |
| Net Cash | -38.06M |
| Net Cash Per Share | -$0.33 |
| Equity (Book Value) | -240.95M |
| Book Value Per Share | -2.11 |
| Working Capital | -59.93M |
Cash Flow
In the last 12 months, operating cash flow was -$8.52 million and capital expenditures -$48,670, giving a free cash flow of -$8.57 million.
| Operating Cash Flow | -8.52M |
| Capital Expenditures | -48,670 |
| Free Cash Flow | -8.57M |
| FCF Per Share | -$0.07 |
Margins
Gross margin is 80.80%, with operating and profit margins of -21.03% and -21.85%.
| Gross Margin | 80.80% |
| Operating Margin | -21.03% |
| Pretax Margin | -21.57% |
| Profit Margin | -21.85% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -38.19% |
Dividends & Yields
Yimutian does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.94% |
| FCF Yield | -1.65% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |